Apoptosis-inducing factor (AIF), a mitochondrial oxidoreductase, is released into the cytoplasm to induce cell death in response to poly(ADP-ribose) (PAR) polymerase-1 (PARP-1) activation. How PARP-1 activation leads to AIF release is not known. Here we identify PAR polymer as a cell death signal that induces release of AIF. PAR polymer induces mitochondrial AIF release and translocation to the nucleus. PAR glycohydrolase, which degrades PAR polymer, prevents PARP-1-dependent AIF release. Cells with reduced levels of AIF are resistant to PARP-1-dependent cell death and PAR polymer cytotoxicity. These results reveal PAR polymer as an AIF-releasing factor that plays important roles in PARP-1-dependent cell death.
A poptosis-inducing factor (AIF), a flavoprotein of Ϸ67 kDa that shares homology with the bacterial oxidoreductases (1), may be a cell death effector that is required for poly(ADPribose) (PAR) polymerase-1 (PARP-1)-mediated cell death (2) (3) (4) . Excessive activation of the nuclear enzyme, PARP-1 plays a prominent role in various of models of cellular injury (5, 6) . PARP-1-dependent toxicity appears to be caspase-independent (4, (7) (8) (9) , and PARP-1 activation is required for AIF translocation during cell death initiated by N-methyl-N-nitro-Nnitrosoguanidine (MNNG) (a DNA alkalating agent that potently activates PARP-1 and elicits PARP-1-dependent cytotoxicity) and hydrogen peroxide in fibroblasts (4) . In the nervous system, AIF translocation occurs after a variety of toxic insults including NMDA-mediated excitotoxicity, trauma, cerebral ischemia, hypoxia͞ischemia, and oxidative stress (4, (10) (11) (12) (13) (14) . NMDA-mediated AIF translocation is PARP-1 dependent (3). Moreover, NMDA glutamate receptor excitotoxicity appears to require AIF as neutralizing AIF antibodies reduce NMDA excitotoxicity (3) and cortical cultures from Harlequin (Hq) mice, which have reduced levels of AIF due to a proviral insertion (15) are resistant to the toxic effects of NMDA (16) and have smaller cerebral infarcts after middle cerebral artery occlusion (2) . How nuclear PARP-1 activation signals to the mitochondria to release AIF is not known. PARP-1-dependent AIF-mediated cell death is heralded by the very early production of PAR polymer (3, 4) . Here we explore AIF release in PARP-1-dependent cell death and report that PAR polymer acts as AIF-releasing factor.
Results

PAR Polymer
Is an AIF-Releasing Factor. A cell-free based system was developed to determine the nature of the signal induced by activation of nuclear PARP-1 that mediates AIF release (Fig. 1) . For these studies, we activated PARP-1 from isolated HeLa cell nuclei and exposed isolated brain mitochondria to the PARP-1-activated HeLa cell nuclei supernatant and monitored AIF release ( Fig. 1 A) . HeLa cell nuclei were used as they are a reliable source of highly purified nuclei of sufficient quantity for downstream assays and analyses. Isolated HeLa cell nuclei were treated with MNNG, ATP, and͞or NAD ϩ to induce PARP-1-activation and formation of PAR polymer formation (Fig. 1B) . PAR polymer formation was monitored by Western blot analysis using a selective and specific antibody to PAR (4, 17, 18) . PAR polymer is only detected in the presence of NAD ϩ in both the nuclear pellet and nuclear supernatant and it is slightly enhanced by the addition of MNNG and ATP (Fig. 1B) . Isolated mitochondria from mouse brain were exposed to the HeLa cell nuclear supernatant in which PARP-1 was activated followed by different treatments of the supernatant (Fig. 1 A) . After centrifugation, the supernatant of the mitochondria was monitored for AIF release (Fig. 1C) . Cytochrome oxidase subunit IV (COX IV) was used to monitor the integrity of the mitochondria and to confirm that equal amounts of mitochondria were used for each incubation. PARP-1-activated nuclear supernatant [SN-(PAR)] induces AIF release from isolated mitochondria (Fig.  1C) , whereas control supernatant [SN(C)] fails to induce AIF release. NAD ϩ alone fails to induce AIF release (Fig. 1C) . SN(PAR) from isolated neuronal nuclei also induces AIF release in a manner similar to HeLa cell nuclei (Fig. 1D) . To begin to characterize the nature of the AIF-releasing factor, SN(PAR) was treated with proteinase K (Pro K) (20 g) for 1 h followed by the inactivation of Pro K with PMSF ( Fig. 1 A and E) . Under these conditions, the majority of proteins are degraded by Pro K as assessed by Coomassie blue staining (Fig. 1E) . Surprisingly, Pro K-treated supernatant still retains AIF-releasing activity (Fig. 1E) . Because it is possible that Pro K treatment of mitochondria could nonspecifically release AIF, mitochondria were treated under identical conditions with Pro K that was inactivated with PMSF, but lacks SN(PAR). Under these conditions, Pro K alone fails to release AIF from the mitochondria (Fig. 1E) . These results suggest that the AIF-releasing activity of SN(PAR) may not be proteinacious.
Because PARP-1 activation leads to PAR polymer formation, we wondered whether the PAR polymer or a PAR modified nuclear protein could act as a AIF-releasing factor. To determine whether PAR polymer is the signal, SN(PAR) was treated with phosphodiesterase 1 (PD1) or poly(ADP-ribose) glycohy-drolase (PARG), which degrade PAR polymers (Figs. 1 A and 2 A) (19, 20) . Under conditions in which PD1 and PARG markedly reduce PAR polymer from SN(PAR) ( Fig. 2A) , AIF is not released from isolated brain mitochondria (Fig. 2B) . These results suggest that PAR polymer or a poly(ADP-ribose) modified nuclear protein is the AIF-releasing factor induced by PARP-1 activation. The AIF release by the PAR moiety of SN(PAR) raised the possibility that PAR polymer itself could function as the AIF-releasing factor. PAR polymer was synthesized and purified after in vitro automodification of PARP-1 and has a mean length of 40 ADP-ribose residues as determined by HPLC methods and gel electrophoresis (21) . The range of size of PAR in this mix is 6-mer through 100-mer ADP-ribose units (21, 22) . Purified PAR polymer induces AIF release in a manner similar to SN(PAR) (Fig. 2C) . In an identical manner to the AIF-releasing activity of SN(PAR), Pro K treatment fails to prevent PAR polymer-induced AIF release (Fig. 2D) . Under conditions in which PARG and PD1 degrade PAR polymer (data not shown) (23), it is not capable of inducing AIF release (Fig. 2E) . Thus, free PAR polymer appears to be an AIFreleasing factor.
To determine the nature of the PAR polymer that mediates AIF release, PAR polymer of different size and complexity ranging in length from 16 to Ͼ60 ADP-ribose residues were evaluated ( Fig. 2F) (22) . An 80 nM concentration of 16 ADPribose residues causes a small amount of AIF release, whereas 80 nM of polymers of 30 ADP-ribose residues induce modest AIF release and 80 nM of polymers greater then 60 ADP-ribose units or the mixed polymer fraction induce robust AIF release (Fig. 2F) . To ascertain whether increasing concentrations of complex polymers greater than 60 ADP-ribose units also lead to more AIF release, we monitored AIF release from isolated mouse brain mitochondria as assessed by subcellular fractionation (Fig. 2G) . PAR polymer (20 nM) induces mild AIF release and AIF release increases with increasing concentration of PAR polymer (Fig. 2G ). These concentrations, length and complexity of PAR polymers are within the range of polymer concentrations and size found in intact cells during NMDA excitotoxicity (3, 4, 17, 23) , and PARP-1-dependent (MNNG-induced) HeLa cell toxicity (data not shown). Thus, it is likely that complex and high molecular weight PAR polymer acts as the nuclear signal to induce mitochondrial release of AIF.
Nuclear and Cytosolic PAR Polymer. The identification of PAR polymer as a nuclear signal that induces mitochondrial AIF release suggests that PAR polymer translocates from the nucleus to the mitochondria to induce AIF release. To determine whether PAR polymer is present in the cytoplasm of intact cells, we evaluated whether NMDA-induced excitotoxicity of primary cortical neurons, a pathophysiologically relevant form of PARP-1-dependent cell death (3), leads to cytosolic PAR polymer formation. PAR polymer formation and localization were monitored via immunohistochemical detection using confocal mi- croscopy and subcellular fractionation followed by Western blot analysis for PAR polymer (Fig. 3) . Fifteen minutes after a 5-min application of NMDA (500 M), PAR polymer is primarily observed in the nucleus of cortical neurons ( Fig. 3 A and C) , but 30 and 60 min after NMDA receptor stimulation, it is localized to cytoplasm as assessed by confocal analysis (Fig. 3A) . High power examination of individual cells clearly shows that PAR polymer is present as a thin cytoplasmic rim around the nucleus of cortical neurons ( Fig. 3B and Fig. 7 , which is published as supporting information on the PNAS web site). Quantitation of the number of cells possessing cytoplasmic PAR polymer indicates that greater than 70% of the cortical neurons following NMDA receptor stimulation have PAR polymer in the cytoplasm, which is consistent with the number of neurons that typically show nuclear condensation following NMDA receptor stimulation (3, 4) (data not shown). Subcellular fractionation of cortical neurons following NMDA receptor stimulation into cytosolic, mitochondrial and nuclear fractions was performed to confirm the confocal analysis (Fig. 3C) . Immunoreactivity for histones, GAPDH, and MnSOD were used to monitor the integrity of the nuclear, cytosolic, and mitochondrial subcellular fractions, respectively (Fig. 3C) . PAR polymer formation is mainly present in the nuclear fraction as early as 15 min after NMDA receptor stimulation, but it is also clearly present in the cytosolic fraction, as well as the mitochondrial fraction, 30 min after NMDA application (Fig. 3C) . To determine whether PAR polymer is localized to the mitochondria, colocalization studies were conducted with PAR polymer and cytochrome oxidase 1 (COX1), an integral mitochondrial protein. Sixty minutes after NMDA (500 M) administration, PAR polymer is colocalized, in part, with COX1 at the mitochondria (Fig. 3D) . Although the exact physiological functions of PAR polymer in other compartments of the cytosol remain unknown, our data demonstrate that PAR polymer generated by NMDA receptor stimulation is in the nucleus and cytosol and that it colocalizes with the mitochondria, where it may act to induce AIF release.
PAR Polymer Induces AIF Release. To investigate whether PAR polymer could induce AIF release in situ from cortical neurons, PAR polymer was applied to cortical neurons via the BioPorter delivery system (24) . PAR polymer is effectively delivered into cortical neurons via the BioPorter reagent as revealed using PAR polymer antibody and confocal imaging (data not shown) (23) . PAR polymer induces AIF translocation and nuclear condensation as monitored via confocal image analysis (Fig. 4 A  and B) . Under conditions in which PARG and PD1 degrade PAR polymer (23) PAR polymer administration via BioPorter delivery to cortical neurons fails to induce AIF translocation and nuclear condensation (Fig. 4 A and B) . Because PAR polymer is a highly negatively charged molecule, the same concentration of poly (adenine) [poly(A)], also negatively charged, was applied via BioPorter to cortical neurons. Poly(A) fails to induce AIF release, indicating that negatively charged polymers are not sufficient to induce AIF release (Fig. 4B) . To confirm the confocal image analysis, subcellular fractionation of cortical neurons was performed after PAR polymer delivery followed by Western blot analysis for AIF, histone, and MnSOD. PAR polymer induces AIF nuclear translocation in cortical neurons, whereas PAR polymer pretreated with PARG or PD1 fails to induce AIF translocation (Fig. 4C) . Poly(A) also fails to induce AIF release as monitored via subcellular fractionation (Fig. 4C) . To ascertain whether there is a reduction in mitochondrial AIF after PAR polymer delivery, the neuronal cultures were subfractionated into nuclear and mitochondrial fractions 6 h after PAR delivery to monitor the change in AIF levels. Accompanying the PAR polymer-induced translocation of mitochondrial AIF to the nucleus is a reduction in mitochondrial AIF (Fig. 4D) , thus loss of AIF in the mitochondrial fraction is attendant on nuclear translocation of AIF by PAR in cortical neurons. As described (4, 17, 25) , cortical neurons from PARP-1-knockout mice are dramatically resistant to NMDA excitotoxicity as NMDA (500 M, 5 min) causes significant neuronal death in wild-type neurons, whereas PARP-1 knockout neurons are completely resistant to the toxic effects of NMDA. Under these conditions AIF is not released from mitochondria (3, 4) . If, however, PAR polymer induces AIF release downstream of PARP-1, then delivery of PAR polymer into PARP-1 KO neurons should bypass PARP-1 inactivation and restore the same pattern of AIF translocation and nuclear condensation as observed in wild-type neurons. To test this idea, PAR polymer was administered to PARP-1 KO cortical neurons (Fig. 4E) . PAR polymer induces AIF nuclear translocation in PARP-1 KO cortical neurons, whereas PAR polymer pretreated with PARG or PD1 fails to induce AIF translocation (Fig. 4 E and F) . Poly(A) also fails to induce AIF release in PARP-1 KO cortical neurons as monitored via subcellular fractionation (Fig. 4F) . These results, taken together, indicate that cytosolic PAR polymer is sufficient to induce AIF release from the mitochondria and induce its translocation to the nucleus. We next evaluated whether interfering with PAR polymer formation induced by PARP-1 activation prevents and͞or reduces AIF translocation in cortical neurons by monitoring AIF translocation following NMDA receptor stimulation with confocal microscopy and subcellular fractionation. Adenoviralmediated overexpression of wild-type cytosolic PARG prevents NMDA-induced AIF translocation as assessed by confocal microscopy whereas overexpression of the catalytically inactive mutant PARG fails to prevent AIF translocation as assessed by confocal microscopy (Fig. 5A) ; and via subcellular fractionation using immunoreactivity for histones and MnSOD to monitor the purity of the nuclear and mitochondrial fractions, respectively (Fig. 5B) . To control for nonspecific effects of adenoviralmediated gene expression, adenoviral-mediated overexpression of GFP was evaluated and it has no effect as NMDA-induced AIF translocation (Fig. 5) . Thus, reducing PAR polymer levels decreases AIF translocation after NMDA excitotoxicity.
To ascertain whether AIF mediates PAR polymer-induced cell death, we used cortical cultures from Hq mutant mice, which contain a proviral insertion in the AIF gene resulting in an 80% of reduction in AIF expression (15) . First, we confirmed that NMDA excitotoxicity is mediated by AIF (2, 3) . Hq cortical cultures are relatively resistant to NMDA excitotoxicity compared with wild-type littermate cortical cultures (Fig. 6 A and B) confirming prior results (2, 3) . NMDA induces an equivalent amount of PAR polymer in both wild-type and Hq mice (Fig.  6C) . Because the reduction in AIF in Hq mice is due to a proviral insertion (15) , it is conceivable that reduction in NMDA excitotoxicity in Hq mice may be due to some other differences unrelated to AIF in the mice. To control for this possibility, we used adenoviral-mediated overexpression of GFP-tagged AIF to replace the reduced AIF. Previously, we and others have shown that GFP-tagged AIF translocates to the nucleus after glutamate excitotoxicity and is fully competent as a death effector (16, 26) . Adenoviral-mediated overexpression of AIF leads to increased levels of AIF in Hq cortical cultures (Fig. 6D) . After restoration of AIF, Hq cortical cultures are rendered susceptible to NMDA excitotoxicity, whereas adenoviral GFP infected Hq cortical cultures are still resistant to the toxic effects of NMDA (Fig. 6E) . Taken together, these results suggest that reduction in cell death observed in Hq mice after NMDA excitotoxicity is due to the reduction in AIF levels. To determine whether AIF plays a role in PAR polymer-mediated toxicity, we evaluated whether Hq cortical cultures are resistant to the toxic effects of BioPortermediated delivery of PAR polymer (Fig. 6 F and G) . Hq cortical neurons are resistant to the toxic effects of PAR polymer compared with wild-type cortical cultures. These results suggest that NMDA excitotoxicity and PAR polymer-induced cell death is mediated, in part, via AIF.
Discussion
The major finding of this paper is that PAR polymer is an AIF-releasing factor. Initially experiments were designed to identify and purify the AIF-releasing factor induced by PARP-1 activation (see Fig. 1 A) . However, through the course of our experiments it became clear that the AIF-releasing factor was not proteinaceous, and that PAR polymer, the major product of PARP-1 activation, was the AIF-releasing factor. Evidence in support that PAR polymer is the AIF-releasing factor include the observations that PARP-1-activated nuclear supernatant induces AIF release from isolated mitochondria and that the AIF-releasing activity is abolished by treatment of PARP-1-activated nuclear supernatant with either PD1 or PARG, which degrade PAR polymer. Moreover, purified PAR polymer induces AIF release from isolated mitochondria and causes the translocation of AIF from the nucleus to the mitochondria in intact cells. In addition, interfering with PAR polymer signaling through PARG overexpression reduces PARP-1-dependent AIF translocation after NMDA excitotoxicity. Our results suggest that excessive activation of PARP-1 leads to an intrinsic cell death program, which we designate as parthanatos to distinguish from necrosis and apoptosis. PAR polymer appears to be a pro-death signaling molecule that acts as a nuclear͞mitochondrial signal to release AIF from the mitochondria in PARP-1 dependent cell death. During PARP-1-dependent cell death, AIF release requires PARP-1 activation as PARP inhibitors or the absence of PARP-1 blocks AIF release (3, 5) . When PARP-1 overactivation occurs, PAR polymer is synthesized in the nucleus and released into the cytoplasm where it leads to AIF release, which then translocates to the nucleus, causing nuclear condensation and cell death. Consistent with the notion that AIF is required for PARP-1-dependent cell death is the observation that neurons from Hq mice with reduced levels of AIF are resistant to the toxic effects of PAR polymer and NMDA excitotoxicity. The mechanism by which PAR polymer causes AIF release is not known. However due to its highly charged nature, it could conceivably depolarize mitochondria leading to permeability transition and subsequent AIF release. Alternatively, PAR polymer could bind to PAR polymer binding proteins (27, 28) at the mitochondria, which then triggers AIF release from the mitochondria. Elucidating these mechanisms and interfering with this bidirectional communication may offer therapeutic approaches to treat cellular injury.
Methods
Primary Cortical Cultures and Cytotoxicity. Primary cortical neuron cultures were prepared from gestational day 14-15 fetal mice, and neurons (14 days in vitro) were exposed to NMDA or PAR polymer and viability was determined by as described (23, 29) .
Immunocytochemistry and Confocal Microscopy. Treated or untreated cortical neurons were stained with an antibody against rabbit polyclonal AIF (4) or rabbit monoclonal AIF antibody (Epitomics, Burlingame, CA) or cytochrome oxidase 1 (COX-1) (Invitrogen, Carlsbad, CA) or anti-PAR polymer antibody (18) and imaged via confocal microscopy using a LSM 510 Meta control.
